Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ · Healthcare
Indivior Pharmaceuticals, Inc. Revenue 2022–2025
Indivior Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Indivior Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 317.0 M, a 19.17% increase year-over-year.
- Indivior Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 1.2 B.
- Indivior Pharmaceuticals, Inc. annual revenue for 2025 was 1.2 B, a 4.29% increase from 2024.
- Indivior Pharmaceuticals, Inc. annual revenue for 2024 was 1.2 B, a 8.69% increase from 2023.
- Indivior Pharmaceuticals, Inc. annual revenue for 2023 was 1.1 B, a 21.31% increase from 2022.
- Indivior Pharmaceuticals, Inc. annual revenue for 2022 was 901.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Indivior Pharmaceuticals, Inc. Earnings — FAQ
Indivior Pharmaceuticals, Inc. (INDV) earnings over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INDV's earnings history?
The chart and table above show Indivior Pharmaceuticals, Inc.'s earnings by year and by quarter, including the growth rate.